ResearcherRoyal Marsden NHS Foundation TrustNo recent work listed
Chiara Braconi
Matched on ORCID iD 0000-0003-4835-1259; OpenAlex author ID A5047404111. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 4 papers
Papers 6
- Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. First author DOI 10.1016/j.annonc.2020.11.013↗
- Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Last author DOI 10.1038/s41467-021-27099-6↗
- Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. Co-author DOI 10.1053/j.gastro.2021.06.080↗
- Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. Co-author DOI 10.1200/jco.20.03238↗
- Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know? Last author DOI 10.2217/fon-2016-0253↗
- miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU… Co-author DOI 10.18632/oncotarget.7208↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Kuang-Fu Chang · 4 shared papers, 2021 · strength 0.41
- Paper Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. DOI 10.1016/j.annonc.2020.11.013↗
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Andrew Victor Biankin · 4 shared papers, 2021 · strength 0.41
- Paper Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. DOI 10.1016/j.annonc.2020.11.013↗
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Raffaella Casolino · 3 shared papers, 2021 · strength 0.33
- Paper Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. DOI 10.1016/j.annonc.2020.11.013↗
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Michèle Milella · 3 shared papers, 2021 · strength 0.33
- Paper Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. DOI 10.1016/j.annonc.2020.11.013↗
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Claudio Bassi · 3 shared papers, 2021 · strength 0.33
- Paper Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. DOI 10.1016/j.annonc.2020.11.013↗
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Aldo Scarpa · 3 shared papers, 2021 · strength 0.29
- Paper Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. DOI 10.1200/jco.20.03238↗
- Paper Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward. DOI 10.1053/j.gastro.2021.06.080↗
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Giuseppe Malleo · 2 shared papers, 2021 · strength 0.23
- Talia Golan · 2 shared papers, 2021 · strength 0.23
- Fieke E. M. Froeling · 2 shared papers, 2021 · strength 0.23
- Salvatore Paiella · 2 shared papers, 2021 · strength 0.23
- Antonio Pea · 2 shared papers, 2021 · strength 0.21
- Vincenzo Corbo · 2 shared papers, 2021 · strength 0.21
- Maria C. Previdi · 2 shared papers, 2017–2021 · strength 0.17
- Pietro Carotenuto · 2 shared papers, 2017–2021 · strength 0.17
- Matteo Fassan · 2 shared papers, 2016–2021 · strength 0.13
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Paper miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic ca… DOI 10.18632/oncotarget.7208↗
- Naureen Starling · 2 shared papers, 2016–2021 · strength 0.13
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Paper miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic ca… DOI 10.18632/oncotarget.7208↗
- David J. Watkins · 2 shared papers, 2016–2021 · strength 0.13
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Paper miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic ca… DOI 10.18632/oncotarget.7208↗
- Ian Chau · 2 shared papers, 2016–2021 · strength 0.13
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Paper miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic ca… DOI 10.18632/oncotarget.7208↗
- David Cunningham · 2 shared papers, 2016–2021 · strength 0.13
- Paper Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. DOI 10.1038/s41467-021-27099-6↗
- Paper miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic ca… DOI 10.18632/oncotarget.7208↗
- Stephan B. Dreyer · 1 shared paper, 2021 · strength 0.12
- Darío Gregori · 1 shared paper, 2021 · strength 0.10
- Roberto Salvia · 1 shared paper, 2021 · strength 0.10
- Jay Campbell · 1 shared paper, 2021 · strength 0.10
- Paola Cappello · 1 shared paper, 2021 · strength 0.10
- Geny Piro · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.